Takeda Pharmaceutical Co Ltd president sells $973,662 in TAK shares on the open market
The sale reduces the insider's holding by 18%, the filing shows.
A Form 4 filed on Nov 4 shows Teresa Marie Bitetti (President) selling 46,609 Takeda Pharmaceutical Co Ltd shares worth $973,662 on Nov 2.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The insider still holds 214,501 shares after the sale, 18% fewer than before.
The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Takeda Pharmaceutical Co Ltd (TAK) |
|---|---|
| Insider | Teresa Marie Bitetti |
| Role | President |
| Transaction | Open-market sale (code S) |
| Shares | 46,609 |
| Average price | $20.89 |
| Value | $973,662 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 4, 2026, 5:35 PM ET |
| Shares held after | 214,501 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See the detailed report on this TAK sale
See earlier insider stories on Takeda Pharmaceutical Co Ltd · See all insider activity at Takeda Pharmaceutical Co Ltd
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
